Experience

Regeneron

• United States
• Biotechnology
• 700 & Above Employee

• Senior Director, Health Economics and Outcomes Research

  • Sep 2020 - Present

  Summary: formulate Health Economics and Outcomes Research (HEOR) strategies and models to promote fair pricing and support early product development to submission. - Partner with cross functional and business partners to develop and support compelling product value propositions with aim to optimize patient access, reimbursement, and uptake. - Develop new methods of modeling relevant to early product development to quantify unmet need, prioritize populations, predict disease burden, and… Show more Summary: formulate Health Economics and Outcomes Research (HEOR) strategies and models to promote fair pricing and support early product development to submission. - Partner with cross functional and business partners to develop and support compelling product value propositions with aim to optimize patient access, reimbursement, and uptake. - Develop new methods of modeling relevant to early product development to quantify unmet need, prioritize populations, predict disease burden, and evaluate trial design. - Identify HEOR evidence requirements and gaps, and design, conduct, and deliver cost-effectiveness and budget impact analyses and models. - Evaluate relevant health technology assessment (HTA) decisions and policies in the US and Ex-US and apply key learnings to marketed and pipeline products. Show less



Evidera

• United States
• Research Services
• 400 - 500 Employee

• Senior Research Scientist and Research Director

  • Mar 2020 - Sep 2020



Evidera (previously United BioSource Corp.)

• Research Scientist

  • Jan 2014 - Mar 2020

  Greater New York City Area - Principle investigator of health economics in drug approval process for major pharmaceuticals. - Led multiple teams (~6 at a time) of researchers specializing in simulation, stats, meta-analysis. - Invented Evidera’s method of discrete events simulation (DES) in Excel. - Brought in projects from major pharmaceuticals in Europe, Asia, North America, and Australia. - Authored multiple publications and poster presentations (can provide references on request) - Collaborated with… Show more - Principle investigator of health economics in drug approval process for major pharmaceuticals. - Led multiple teams (~6 at a time) of researchers specializing in simulation, stats, meta-analysis. - Invented Evidera’s method of discrete events simulation (DES) in Excel. - Brought in projects from major pharmaceuticals in Europe, Asia, North America, and Australia. - Authored multiple publications and poster presentations (can provide references on request) - Collaborated with pharmaceuticals and clinical experts in clinical trial design - Managed project tasks, timelines, and budgets greater than $150,000 - Employed regression analyses and other statistical methods to predict risk of disease in simulation - Modeling instructor for junior and senior staff Show less



UBC

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Senior Research Associate

  • Sep 2005 - Dec 2013

  Expert cost-effectiveness modeler, modeling instructor, and project leader at UBC. Spearheaded development of new modeling methods and techniques. Authored multiple publications and poster presentations (publications provided upon request).



Agency for Healthcare Research and Quality

• Fellowship

  • 2004 - 2005

  Conducted a literature review of cost-effectiveness analyses (CEA) of major therapies in key disease areas. Produced a report assessing integrity of CEA conclusions and application to US policy.



KFF

• United States
• Non-profit Organizations
• 100 - 200 Employee

• Fellowship

  • 2003 - 2004

  Managed public health statistics and data on statehealthfacts.org for all US states, counties, and territories.